Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Antibody Actions01:26

Antibody Actions

1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

12.9K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or...
12.9K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

7.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Bradykinin contributes to vasogenic edema in murine experimental cerebral malaria.

The Journal of clinical investigation·2026
Same author

Antiphospholipid syndrome (APS) is a platelet factor 4 (PF4)-centric immunothrombotic disorder.

Blood·2026
Same author

A call to action for the use of composite hematologic measurements in hereditary hemorrhagic telangiectasia and other chronic bleeding disorders.

Expert review of hematology·2026
Same author

Correction: PIGN spatiotemporally regulates the spindle assembly checkpoint proteins in leukemia transformation and progression.

Scientific reports·2026
Same author

Noninvasive Monitoring of Complement Using the Bioluminescent Modified Ham Assay in the Second Porcine-to-Human Live Heart Transplant.

Xenotransplantation·2026
Same author

Bradykinin Contributes to Vasogenic Edema in Murine Experimental Cerebral Malaria.

bioRxiv : the preprint server for biology·2026

相关实验视频

Updated: Jun 24, 2025

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

30.6K

补充生物传感器识别了在补充介导的血溶性尿素综合征中的经典途径刺激.

Michael A Cole, Nikhil Ranjan, Gloria F Gerber

    bioRxiv : the preprint server for biology
    |June 10, 2024
    PubMed
    概括

    补充介导的血溶性尿素综合征 (CM-HUS) 诊断得到了新的基于细胞的生物传感器的改进. 这些工具可以识别IgM驱动的刺激,解释CM-HUS缺少替代途径变异的病例.

    更多相关视频

    Measuring the 50% Haemolytic Complement CH50 Activity of Serum
    08:26

    Measuring the 50% Haemolytic Complement CH50 Activity of Serum

    Published on: March 29, 2010

    37.8K
    Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry
    07:20

    Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry

    Published on: May 19, 2020

    7.2K

    相关实验视频

    Last Updated: Jun 24, 2025

    Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
    06:29

    Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

    Published on: January 29, 2014

    30.6K
    Measuring the 50% Haemolytic Complement CH50 Activity of Serum
    08:26

    Measuring the 50% Haemolytic Complement CH50 Activity of Serum

    Published on: March 29, 2010

    37.8K
    Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry
    07:20

    Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry

    Published on: May 19, 2020

    7.2K

    科学领域:

    • 免疫学 免疫学 免疫学
    • 血液学 血液学 血液学
    • 生物技术是生物技术.

    背景情况:

    • 补充介导的血溶性尿素综合征 (CM-HUS) 是一种严重的血栓性微血管病变.
    • 诊断通常依赖于识别影响补体调节的遗传变异或抗体.
    • 现有的诊断方法可能无法完全解释所有CM-HUS病例.

    研究的目的:

    • 开发和验证新的基于细胞的补充生物传感器,用于CM-HUS诊断.
    • 研究补充通路的作用,特别是IgM驱动的刺激,在CM-HUS病变发生过程中.
    • 评估这些生物传感器在监测补充抑制剂治疗中的有用性.

    主要方法:

    • 设计了缺乏特定补充调节蛋白 (CD55,CD59,CD46) 的HEK293细胞,以创建生物发光生物传感器.
    • 使用修改后的Ham (mHam) 测试框架进行ex vivo补充分析.
    • 采用特定的补充通路抑制剂来剖析通路激活.

    主要成果:

    • 开发的生物传感器有效地诊断CM-HUS并监测补体阻塞.
    • 在CM-HUS患者中确定了IgM驱动的古典通路刺激,即使在缓解期间.
    • 这一发现可能解释了~50%的CM-HUS没有替代途径变异的病例.

    结论:

    • 基于细胞的补体生物传感器为CM-HUS.US提供了一个敏感的诊断工具.
    • 一个CM-HUS的子集可能是由于IgM免疫耐受性的分解而产生的.
    • 这些生物传感器可以帮助诊断CM-HUS,并指导补充抑制剂治疗.